Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME‐V study)-Reference-Cited by-同舟云学术

Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME‐V study)

Published:2020-08-20 Issue:2 Volume:12 Page:200-206
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Koshizaka Masaya¹²^ORCID,Ishikawa Ko¹²,Ishibashi Ryoichi²³,Maezawa Yoshiro¹²^ORCID,Sakamoto Kenichi²,Uchida Daigaku⁴,Nakamura Susumu⁵,Yamaga Masaya⁶,Yokoh Hidetaka¹²^ORCID,Kobayashi Akina¹²,Onishi Shunichiro⁷,Kobayashi Kazuki²⁷,Ogino Jun⁸,Hashimoto Naotake⁸,Tokuyama Hirotake⁹,Shimada Fumio¹⁰,Ohara Emi¹⁰,Ishikawa Takahiro¹¹¹,Shoji Mayumi¹²,Ide Shintaro¹²,Ide Kana¹²,Baba Yusuke¹²^ORCID,Hattori Akiko¹²,Kitamoto Takumi¹²,Horikoshi Takuro¹²,Shimofusa Ryouta¹³,Takahashi Sho¹⁴,Nagashima Kengo¹⁵^ORCID,Sato Yasunori¹⁶,Takemoto Minoru¹⁷^ORCID,Newby L. Kristin¹⁸,Yokote Koutaro¹²^ORCID,

Affiliation:

1. Department of Medicine Division of Diabetes, Metabolism and Endocrinology Chiba University Hospital Chiba Japan

2. Department of Endocrinology, Hematology, and Gerontology Chiba University Graduate School of Medicine Chiba Japan

3. Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism Kimitsu Chuo Hospital Kisarazu Japan

4. Hotaruno Central Naika Kisarazu Japan

5. Odayama Clinic Kisarazu Japan

6. Department of Diabetes and Metabolism Japanese Red Cross Narita Hospital Narita Japan

7. Department of Diabetes and Metabolism Asahi General Hospital Asahi Japan

8. Department of Diabetes, Endocrine and Metabolic Disease Tokyo Women's Medical University Yachiyo Medical Center Yachiyo Japan

9. Yukarigaoka Tokuyama Medical Clinic Sakura Japan

10. Department of Diabetes and Metabolism National Hospital Organization Chiba Medical Center Chiba Japan

11. Geriatric Medical Center Chiba University Hospital Chiba Japan

12. Diagnostic Radiology and Radiation Oncology Chiba University Graduate School of Medicine Chiba Japan

13. Department of Radiology Sannou Hospital Chiba Japan

14. Clinical Research Support Center The Jikei University School of Medicine Tokyo Japan

15. Research Center for Medical and Health Data Science The Institute of Statistical Mathematics Tachikawa Japan

16. Department of Preventive Medicine and Public Health Keio University School of Medicine Shinjuku‐ku Japan

17. Department of Medicine Division of Diabetes, Metabolism and Endocrinology International University of Health and Welfare Narita Japan

18. Duke Clinical Research Institute Duke University Medical Center Durham North Carolina USA

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13340

Reference27 articles.

1. Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives

2. The Effects of Dipeptidyl Peptidase-4 Inhibitors in Treatment of Obese Patients with Type 2 Diabetes

3. Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor sitagliptin compared with alpha‐glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin‐1): A multicenter, randomized, open‐label, non‐inferiority trial

4. Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study)

5. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone effects of metformin monotherapy and its combination with teneligliptin: A 12-week follow-up study in patients with type 2 diabetes mellitus;Diabetes Research and Clinical Practice;2024-07

2. Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved;Clinical Nutrition;2023-12

3. Metabolomic analysis of serum samples from a clinical study on ipragliflozin and metformin treatment in Japanese patients with type 2 diabetes: Exploring human metabolites associated with visceral fat reduction;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-10-12

4. Relationship between sodium–glucose cotransporter-2 inhibitors and muscle atrophy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis;Frontiers in Endocrinology;2023-09-15

5. Diet, exercise, and pharmacotherapy for sarcopenia in people with diabetes;Metabolism;2023-07